SCHEMBL4632079

SCHEMBL4632079

CCCN(CC(=O)O)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 4/20 0.46
CA9 Q16790 4/20 0.46
CA2 P00918 3/20 0.46
TSHR P16473 2/20 0.43
MAPK1 P28482 1/20 0.43
TDP1 Q9NUW8 3/20 0.42
EYA2 O00167 1/20 0.42
APP P05067 1/20 0.42
ACE P12821 1/20 0.42
BLM P54132 2/20 0.40
PMP22 Q01453 2/20 0.40
ALDH1A1 P00352 1/20 0.40
HPGD P15428 1/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
CHRM2 P08172 1/20 0.40
ADRA2A P08913 1/20 0.40
ALOX15 P16050 1/20 0.40
DRD1 P21728 1/20 0.40
SLC6A2 P23975 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7562613 0.84 AKR1B1 (0.44) CA12CA9CA2TSHRTDP1
SCHEMBL41505 0.84 CA12 (0.55) CA12CA9CA2TSHRMAPK1
SCHEMBL30241145 0.83 CA12 (0.44) CA12CA9CA2TSHRMAPK1
SCHEMBL6636451 0.82
Bromide SCHEMBL11753648 0.81 CA12 (0.52) CA12CA9CA2TSHRMAPK1
Hydrochloric Acid SCHEMBL10822973 0.81 CA12 (0.52) CA12CA9CA2TSHRMAPK1
SCHEMBL5080836 0.81 CA12 (0.43) CA12CA9CA2TSHRMAPK1
SCHEMBL28206109 0.81 CA12 (0.43) CA12CA9CA2TSHRMAPK1
SCHEMBL331800 0.79
SCHEMBL8891629 0.79 LMNA (0.40) CA12CA9TSHRMAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109069877-A The composition containing polycarbodiimide and amino-compound for treatment of keratinous substrates 欧莱雅 2018-12-21 CN disclosed
EP-1924292-A2 COMPOSITIONS AND METHODS FOR THE INTRAOCULAR TRANSPORT OF THERAPEUTIC AGENTS Allergan, Inc. (US) 2008-05-28 EP disclosed
WO-2007037849-A2 COMPOSITIONS AND METHODS FOR THE INTRAOCULAR TRANSPORT OF THERAPEUTIC AGENTS ALLERGAN, INC. (US) 2007-04-05 WO disclosed